OPMI donates terms to the Clinical Trial Ontology (CTO)

[yongqunh]

Dr. Oliver He and the OPMI team have been collaborating with Drs. Leon Li and Evan Bolton from NIH and Asiyah Lin from FDA to develop many clinical trial-specific terms to support the clinicaltrials.gov data standardization and integration, with an application to ingrate the clinical trial data with the data in PubChem. Later we also started to collaborate with Stephan Gebel and his group in Germany on this work. Stephan and his group had developed a Clinical Trial Ontology (CTO). After discussion, we decided to restructure the CTO based on the OBO Foundry principles and OBO ontology development methods. Oliver, Asiyah, and Leon actively worked with Stephan and his team to make the restructuring.
See the meeting notes on the collaborative work between OPMI and CTO project teams:
https://docs.google.com/document/d/1VnmFhqFwfH3qcShiZUTO9ALF-3JKCs2oa3MQ2LotH6U/edit

To make CTO more a reference ontology, in the meeting on May 15, 2020, Oliver proposed and agreed to donate a set of clinical trial-specific OPMI terms originally defined in OPMI to the new CTO ontology. See more information on the CTO tracker issue:
ClinicalTrialOntology/CTO#10

This is still an ongoing process. Any suggestions and comments are welcome.